P30-38 Towards phasing out acute toxicity in vivo testing in EU chemical safety assessments
Prachi Pradeep(Research Triangle Park Foundation), Tomasz Sobański(Finnish Safety and Chemicals Agency), Ulla Simanainen(European Chemicals Agency), Ralph Pirow(Federal Institute for Risk Assessment), S. Schmeisser(Federal Institute for Risk Assessment), Mounir Bouhifd(Finnish Safety and Chemicals Agency), Kamel Mansouri, Boris Schmitt(Berlin-Brandenburger Centrum für Regenerative Therapien), J.L.C.M. Dorne, Nicole Kleinstreuer(Division of Program Coordination Planning and Strategic Initiatives), Andrew S. Weyrich(Oklahoma Medical Research Foundation), Matthias Herzler(Federal Institute for Risk Assessment), Katrin Schütte(European Commission)
Cited by 1
Related Papers
In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury.
|Journal of Clinical Investigation|1993|452
Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation
|Blood|2013|349
The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat.
|Circulation|1992|323
Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspases
|Journal of Thrombosis and Haemostasis|2013|221